Tumor-stroma interactions;La relation tumeur-stroma

Bulletin du Cancer

Volumn 95, Issue 1, 2008, Pages 51-56

  Billottet, Clotilde ^a   Jouanneau, Jacqueline ^b  

^a INSERM   (France)

^b Bulletin du Cancer ^*  (France)

Author keywords

Carcinoma; Fibroblasts; Oncogenic signals; Stroma; Therapeutic targets

Indexed keywords

BEVACIZUMAB; CYTOKINE; GROWTH FACTOR; IMATINIB; ENDOTHELIAL CELL GROWTH FACTOR; ENZYME INHIBITOR; MATRIX METALLOPROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; CARCINOGENESIS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PROTEIN DEGRADATION; REVIEW; STROMA; TUMOR; TUMOR CELL; TUMOR GROWTH; CANCER INVASION; CARCINOMA; CELL COMMUNICATION; CELL MEMBRANE; DISEASE COURSE; DRUG ANTAGONISM; FIBROBLAST; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STROMA CELL; VASCULARIZATION;

CARCINOMA; CELL COMMUNICATION; CELL MEMBRANE; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FIBROBLASTS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 39149089379     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0560     Document Type: Review

References (39)

1. Benard J. Microenvironment and tumor progression : the progress concept. Bull Cancer 2004 ; 91 : 663-5.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996 ; 86 : 353-64.
3. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003 ; 9 : 653-60.
4. Li H, Fan X, Houghton J. Tumor microenvironment : the role of the stroma in cancer. J Cell Biochem 2007 ; 101 : 805-15.
5. Weaver VM, Fischer AH, Peterson OW, Bissell MJ. The importance of the microenvironment in breast cancer progression : recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem Cell Biol 1996 ; 74 : 833-51.
6. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003 ; 15 : 740-6.
7. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, Sime PJ, et al. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 2006 ; 35 : 297-325.
8. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006 ; 6 : 392-401.
9. Kalluri R. Basement membranes : structure, assembly and role in tumor angiogenesis. Nat Rev Cancer 2003 ; 3 : 422-33.
10. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblats in cancer initiation and progression. Nature 2004 ; 432 : 332-7.
11. Witz IP. Tumor microenvironment : the role of the tumor stroma in cancer. Cancer Lett 2006 ; 242 : 1-6.
12. Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cyt Growth Factor Rev 2005 ; 16 : 179-86.
13. Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, et al. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 1996 ; 56 : 2440-5.
14. Matsumoto K, Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 2006 ; 119 : 477-83.
15. Funasaka T, Raz A. The role of autocrine motility factor in tumor and tumor microenvironment. Cancer Metastasis Rev 2007 ; 8 ; [Epub ahead of print].
16. Jiang WG, Raz A, Douglas-Jones A, Mansel RE. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer. J Histochem Cytochem 2006 ; 54 : 231-41.
17. Bikfalvi A. Angiogenèse tumorale. Bull Cancer 2007 ; 94 : F193-F198.
18. Bierie B, Moses HL. Tumour microenvironment : TGFbeta : the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006 ; 6 : 506-20.
19. Marinkovich MP. Laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 2007 ; 7 : 370-80.
20. McCawley IJ, Matrisian L. Matrix metalloproteinases : multifunctional contributors to tumor progression. Mol Med Today 2000 ; 6 : 149-56.
21. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001 ; 17 : 463-516.
22. Lynch CC, Matrisian L. Matrix metalloproteases in tumor-host cell communication. Differentiation 2002 ; 70 : 561-73.
23. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000 ; 2 : 737-44.
24. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003 ; 9 : 685-93.
25. Farace F, Bidart JM. Les cellules endothéliales circulantes : biomarqueurs d'efficacité de la thérapie antiangiogénique. Bull Cancer 2007 ; 94 : S254-S259.
26. Fukumura D, Jain RK. Tumor microenvironment abnormalities : causes, consequences, and strategies to normalize. J Cell Biochem 2007 ; 101 : 937-49.
27. André F, Soria JC, Assi H, Delaloge S, Spielmann M. Expression des récepteurs aux chimiokines par les cellules cancéreuses. Bull Cancer 2004 ; 91 : S254-S256.
28. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004 ; 4 : 540-50.
29. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, et al. Expression of CXCR4 enhances the pulmonary metastatic potential of murine B16 melonoma cells. Cancer Res 2002 ; 62 : 7328-34.
30. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007 ; 449 : 557-63.
31. Allinen M, Beronbhim R, Cai L, Lahti-Domenici J, Huang H, Porter D, et al. Molecular characterization of the tumor microenvironment i breast cancer. Cancer Cell 2004 ; 6 : 17-32.
32. Cowherd SM, Espina VA, Petricoin EF, Liotta LA. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. Clin Breast Cancer 2004 ; 5 : 385-92.
33. Schmeichel KL, Bissel MJ. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 2003 ; 116 : 2377-88.
34. Sheehan KM, Gulmann C, Eichler GS, Weinstein JN, Barrett HL, Kay EW, et al. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene 2007 ; [advance online publication].
35. Ruegg C, Mutter N. Anti-angiogenic therapies in cancer : achievements and open questions. Bull Cancer 2007 ; 94 : 753-62.
36. Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Res 2005 ; 7 : 513-52.
37. Têtu B, Trudel D, Wang CS. Protéases des cellules stromales réactionnelles du cancer : une cible thérapeutique attrayante. Bull Cancer 2006 ; 93 : 944-8.
38. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer : trials and tribulations. Science 2002 ; 295 : 2387-92.
39. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F. Mesenchymal stem cells in cancer : tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 2007 ; 86 : 8-16.